Research output per year
Research output per year
Personal profile
Research interests
Molecular parasitology, malaria, epidemiology, genomics, evolution, diagnosis, drug resistance
External positions
editorial board of Acta Tropica
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 6 Clean Water and Sanitation -
SDG 10 Reduced Inequalities -
SDG 12 Responsible Consumption and Production -
SDG 15 Life on Land -
SDG 16 Peace, Justice and Strong Institutions -
SDG 17 Partnerships for the Goals
Fingerprint
Dive into the research topics where Mallika Imwong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
PLATCOV Collaborative Group, Feb 2026, In: The Lancet Infectious Diseases. 26, 2, p. 139-147 9 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Citations (Scopus) -
A sustainable house design to improve child health in rural Africa: a cluster-randomized controlled trial
Mshamu, S., Mukaka, M., Sanga, C., Kambanga, S., Rutaihwa, A. D., Bøjstrup, T. C., Meta, J., Mmbando, A., Pell, C., Adhikari, B., Olotu, A. I., Kapologwe, N., White, N. J., Dondorp, A. M., Day, N. P. J., Imwong, M., Deen, J., Lindsay, S. W., Knudsen, J. B. & von Seidlein, L., Jun 2026, In: Nature Medicine. 32, 6, p. 2294-2301 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial
AD ASTRA Collaborative Group, 2026, (Accepted/In press) In: The Lancet Infectious Diseases.Research output: Contribution to journal › Article › peer-review
Open Access -
Changing genetic profiles of Plasmodium falciparum piperaquine resistance in Southeast Asia over 25 years
Srisutham, S., Suwannasin, K., Saejeng, A., Khantikul, N., Sugaram, R., Phyo, A. P., Proux, S., Pongvongsa, T., Nguon, C., Tripura, R., Chau, N. H., Lek, D., Trung, N. H. D., Peto, T. J., Callery, J. J., van der Pluijm, R. W., Amaratunga, C., Dhorda, M., von Seidlein, L. & Mayxay, M. & 9 others, , Apr 2026, In: Antimicrobial Agents and Chemotherapy. 70, 4Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Characterizing viral clearance kinetics in acute influenza
Wongnak, P., Seers, T., Jittamala, P., Imwong, M., Schilling, W., Watson, J. & White, N. J., 30 Apr 2026, In: Philosophical Transactions of the Royal Society B: Biological Sciences. 381, 1949, 20240351.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)